Skip to main content
. 2018 Feb 15;11(1):1433987. doi: 10.1080/16549716.2018.1433987

Table 4.

Perceived barriers toward compliance to HBV antiviral therapy among patients with medium and low adherence in rank order (n = 308).

Barriers n (%)
(1) Medication(s) are expensive and difficult to afford 150 (48.7)
(2) Forgetfulness 139 (45.1)
(3) Have experienced or worry about potential side effects 61 (19.8)
(4) Do not want others to know about my medication(s) usage 57 (18.5)
(5) Ran out of pills and do not have time to refill 49 (15.9)
(6) Feel better already and do not think it is necessary to continue 41 (13.3)
(7) Multiple medications are taken daily and cannot keep track of the dose for each 37 (12.0)
(8) Cannot tell the difference between taking/not taking medication(s) 33 (10.7)
(9) Insurance does not provide coverage when cost exceeds the limit 32 (10.4)
(10) Emotionally distressed about disease condition and have no desire to continue 15 (4.9)
(11) Physician did not inform me about the importance of taking medication(s) timely 7 (2.3)
(12) Difficulty swallowing 3 (1.0)